Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_assertion type Assertion NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_head.
- NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_provenance.
- NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_assertion evidence source_evidence_literature NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_provenance.
- NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_assertion SIO_000772 17554795 NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_provenance.
- NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_assertion wasDerivedFrom befree-2016 NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_provenance.
- NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_assertion wasGeneratedBy ECO_0000203 NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_provenance.